Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases

Vaccination is significant to control, mitigate, and recover from the destructive effects of coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 vaccination has been increasing and growing public concern; however, little is known about it. This study aimed to system...

Full description

Bibliographic Details
Main Authors: Pandit Bagus Tri Saputra, Roy Bagus Kurniawan, Desy Trilistyoati, Makhyan Jibril Al Farabi, Hendri Susilo, Mochamad Yusuf Alsagaff, Yudi Her Oktaviono, Henry Sutanto, Arief Gusnanto, Citrawati Dyah Kencono Wungu
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-07-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/8779
_version_ 1797261376139296768
author Pandit Bagus Tri Saputra
Roy Bagus Kurniawan
Desy Trilistyoati
Makhyan Jibril Al Farabi
Hendri Susilo
Mochamad Yusuf Alsagaff
Yudi Her Oktaviono
Henry Sutanto
Arief Gusnanto
Citrawati Dyah Kencono Wungu
author_facet Pandit Bagus Tri Saputra
Roy Bagus Kurniawan
Desy Trilistyoati
Makhyan Jibril Al Farabi
Hendri Susilo
Mochamad Yusuf Alsagaff
Yudi Her Oktaviono
Henry Sutanto
Arief Gusnanto
Citrawati Dyah Kencono Wungu
author_sort Pandit Bagus Tri Saputra
collection DOAJ
description Vaccination is significant to control, mitigate, and recover from the destructive effects of coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 vaccination has been increasing and growing public concern; however, little is known about it. This study aimed to systematically review myocarditis following COVID-19 vaccination. We included studies containing individual patient data of myocarditis following COVID-19 vaccination published between January 1, 2020 and September 7, 2022 and excluded review articles. Joanna Briggs Institute critical appraisals were used for risk of bias assessment. Descriptive and analytic statistics were performed. A total of 121 reports and 43 case series from five databases were included. We identified 396 published cases of myocarditis and observed that the majority of cases was male patients, happened following the second dose of mRNA vaccine administration, and experienced chest pain as a symptom. Previous COVID-19 infection was significantly associated (p < 0.01; OR, 5.74; 95% CI, 2.42–13.64) with the risk of myocarditis following the administration of the first dose, indicating that its primary mechanism is immune-mediated. Moreover, 63 histopathology examinations were dominated by non-infective subtypes. Electrocardiography and cardiac marker combination is a sensitive screening modality. However, cardiac magnetic resonance is a significant noninvasive examination to confirm myocarditis. Endomyocardial biopsy may be considered in confusing and severe cases. Myocarditis following COVID-19 vaccination is relatively benign, with a median length of hospitalization of 5 days, intensive care unit admission of <12%, and mortality of <2%. The majority was treated with nonsteroidal anti-inflammatory drugs, colchicine, and steroids. Surprisingly, deceased cases had characteristics of being female, older age, non-chest pain symptoms, first-dose vaccination, left ventricular ejection fraction of <30%, fulminant myocarditis, and eosinophil infiltrate histopathology.
first_indexed 2024-04-24T23:40:14Z
format Article
id doaj.art-87cd0c1c5ec142638dbf13f218606c39
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:40:14Z
publishDate 2023-07-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-87cd0c1c5ec142638dbf13f218606c392024-03-15T13:22:31ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2023-07-0123410.17305/bb.2022.8779Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of casesPandit Bagus Tri Saputra0https://orcid.org/0000-0002-5815-0592Roy Bagus Kurniawan1https://orcid.org/0000-0002-4220-8286Desy Trilistyoati2Makhyan Jibril Al Farabi3Hendri Susilo4https://orcid.org/0000-0002-5603-9487Mochamad Yusuf Alsagaff5Yudi Her Oktaviono6Henry Sutanto7Arief Gusnanto8https://orcid.org/0000-0001-5748-784XCitrawati Dyah Kencono Wungu9https://orcid.org/0000-0001-5180-957XDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga–Dr Soetomo General Academic Hospital, Surabaya, IndonesiaFaculty of Medicine, Universitas Airlangga, Surabaya, IndonesiaFaculty of Medicine, Universitas Airlangga, Surabaya, IndonesiaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga–Dr Soetomo General Academic Hospital, Surabaya, IndonesiaDepartment of Cardiology and Vascular Medicine, Universitas Airlangga Hospital, Surabaya, IndonesiaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga–Dr Soetomo General Academic Hospital, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Universitas Airlangga Hospital, Surabaya, IndonesiaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga–Dr Soetomo General Academic Hospital, Surabaya, IndonesiaDepartment of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, ‎NetherlandsSchool of Mathematics, University of Leeds, Leeds, UKDepartment of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia Vaccination is significant to control, mitigate, and recover from the destructive effects of coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 vaccination has been increasing and growing public concern; however, little is known about it. This study aimed to systematically review myocarditis following COVID-19 vaccination. We included studies containing individual patient data of myocarditis following COVID-19 vaccination published between January 1, 2020 and September 7, 2022 and excluded review articles. Joanna Briggs Institute critical appraisals were used for risk of bias assessment. Descriptive and analytic statistics were performed. A total of 121 reports and 43 case series from five databases were included. We identified 396 published cases of myocarditis and observed that the majority of cases was male patients, happened following the second dose of mRNA vaccine administration, and experienced chest pain as a symptom. Previous COVID-19 infection was significantly associated (p < 0.01; OR, 5.74; 95% CI, 2.42–13.64) with the risk of myocarditis following the administration of the first dose, indicating that its primary mechanism is immune-mediated. Moreover, 63 histopathology examinations were dominated by non-infective subtypes. Electrocardiography and cardiac marker combination is a sensitive screening modality. However, cardiac magnetic resonance is a significant noninvasive examination to confirm myocarditis. Endomyocardial biopsy may be considered in confusing and severe cases. Myocarditis following COVID-19 vaccination is relatively benign, with a median length of hospitalization of 5 days, intensive care unit admission of <12%, and mortality of <2%. The majority was treated with nonsteroidal anti-inflammatory drugs, colchicine, and steroids. Surprisingly, deceased cases had characteristics of being female, older age, non-chest pain symptoms, first-dose vaccination, left ventricular ejection fraction of <30%, fulminant myocarditis, and eosinophil infiltrate histopathology. https://www.bjbms.org/ojs/index.php/bjbms/article/view/8779myocarditisCOVID-19 vaccinationvaccineSARS-CoV2side effect
spellingShingle Pandit Bagus Tri Saputra
Roy Bagus Kurniawan
Desy Trilistyoati
Makhyan Jibril Al Farabi
Hendri Susilo
Mochamad Yusuf Alsagaff
Yudi Her Oktaviono
Henry Sutanto
Arief Gusnanto
Citrawati Dyah Kencono Wungu
Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
Biomolecules & Biomedicine
myocarditis
COVID-19 vaccination
vaccine
SARS-CoV2
side effect
title Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
title_full Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
title_fullStr Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
title_full_unstemmed Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
title_short Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases
title_sort myocarditis and coronavirus disease 2019 vaccination a systematic review and meta summary of cases
topic myocarditis
COVID-19 vaccination
vaccine
SARS-CoV2
side effect
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/8779
work_keys_str_mv AT panditbagustrisaputra myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT roybaguskurniawan myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT desytrilistyoati myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT makhyanjibrilalfarabi myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT hendrisusilo myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT mochamadyusufalsagaff myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT yudiheroktaviono myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT henrysutanto myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT ariefgusnanto myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases
AT citrawatidyahkenconowungu myocarditisandcoronavirusdisease2019vaccinationasystematicreviewandmetasummaryofcases